Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients

Table 1

The clinicopathological features of the study subjects.

Clinicopathological features	Number
Patients with PTC (𝑛=52)
Age
<45 years	32
≥45 years	20
Sex
Male	15
Female	37
Tumor size
<2 cm	31
≥2 cm	21
TNM staging
I	38
II	4
III	3
IV	7
Heteromorphic nucleus	6
Multicentricity	20
Tumor location
Unilateral	45
Bilateral	7
Cervical LN metastasis	29
BRAF gene mutation	19
AMES
Low risk	45
High risk	7
Thyroglobulin level
Low	3
Normal	35
High	14
Patients with BTN (𝑛=52)
Age
<45 years	34
≥45 years	18
Sex
Male	12
Female	40
Nodule
Solitary nodule	28
Multinodule	24

TNM: tumor node metastasis; LN: lymph nodes; AMES: age, metastasis to distant sites, extrathyroidal invasion, and tumor size scoring system.